BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25229569)

  • 1. Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa.
    Buimer MG; Wobbes T; Klinkenbijl JH; Reijnen MM; Blokx WA
    Am J Dermatopathol; 2015 Feb; 37(2):129-32. PubMed ID: 25229569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement.
    Heller DS; Haefner HK; Hameed M; Lieberman RW
    J Reprod Med; 2002 Sep; 47(9):695-700. PubMed ID: 12380447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
    Selim AG; Wells CA
    J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
    Kővári B; Kocsis L; Varga E; Cserni G
    Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical-pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two.
    Fismen S; Ingvarsson G; Moseng D; Nathalie Dufour D; Jørgensen L
    APMIS; 2012 Jun; 120(6):433-40. PubMed ID: 22583355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinologic Aspects of Hidradenitis Suppurativa.
    Karagiannidis I; Nikolakis G; Zouboulis CC
    Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific.
    Zouboulis CC; Nogueira da Costa A; Fimmel S; Zouboulis KC
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1555-1563. PubMed ID: 32031713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands.
    Attanoos RL; Appleton MA; Douglas-Jones AG
    Br J Dermatol; 1995 Aug; 133(2):254-8. PubMed ID: 7547393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
    Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
    Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of androgen receptors in the clinical course of nevus sebaceus of Jadassohn.
    Hamilton KS; Johnson S; Smoller BR
    Mod Pathol; 2001 Jun; 14(6):539-42. PubMed ID: 11406653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apocrine metaplasia of breast cancer: clinicopathological features and predicting response.
    Ogiya A; Horii R; Osako T; Ito Y; Iwase T; Eishi Y; Akiyama F
    Breast Cancer; 2010 Oct; 17(4):290-7. PubMed ID: 19789945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.
    Diaz de Leon E; Carcangiu ML; Prieto VG; McCue PA; Burchette JL; To G; Norris BA; Kovatich AJ; Sanchez RL; Krigman HR; Gatalica Z
    Am J Clin Pathol; 2000 Apr; 113(4):572-5. PubMed ID: 10761460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
    Karagiannidis I; Nikolakis G; Sabat R; Zouboulis CC
    Rev Endocr Metab Disord; 2016 Sep; 17(3):335-341. PubMed ID: 27294593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology of hidradenitis suppurativa.
    Jemec GB; Hansen U
    J Am Acad Dermatol; 1996 Jun; 34(6):994-9. PubMed ID: 8647993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of hidradenitis suppurativa: An update.
    Prens E; Deckers I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S8-11. PubMed ID: 26470623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.
    Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S48-50. PubMed ID: 25188457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.